Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Sell
31
BCAX Quote, Financials, Valuation and Earnings
Last price:
$16.79
Seasonality move
:
-32.17%
Day range:
$16.71 - $17.30
52-week range:
$7.80 - $19.71
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
2.29x
Volume:
275.7K
Avg. volume:
688.9K
1-year change:
-12.13%
Market cap:
$920.3M
Revenue:
--
EPS (TTM):
-$2.23
Earnings Data
Next earnings date for BCAX
Mar 26
2026
Most recent earnings per share
-$0.67
Missed by $0.13
(Nov 10/2025)
Consensus Estimate
-$0.53
(Nov 10/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
BCAX Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 03/26/2026 | Q4 | -- | -- | -- | -$0.67 | -- |
| 11/10/2025 | Q3 | -- | -- | -$0.67 | -$0.53 | -$0.13 |
| 08/12/2025 | Q2 | -- | -- | -$0.50 | -$0.54 | $0.03 |
| 05/13/2025 | Q1 | -- | -- | -$0.68 | -$0.40 | -$0.28 |
| 03/27/2025 | Q4 | -- | -- | -$0.39 | -$0.28 | -$0.10 |
| 11/12/2024 | Q3 | -- | -- | -$1.60 | -$0.50 | -$1.10 |
| 06/30/2024 | Q2 | -- | -- | -$0.33 | -$0.43 | $0.10 |
| 03/31/2024 | Q1 | -- | -- | -- | -$0.43 | -- |
Bicara Therapeutics, Inc. Earnings Questions
-
How Much did Bicara Therapeutics, Inc. Generate in Revenue Last Quarter?
Bicara Therapeutics, Inc. reported -- worth of top line sales in its most recent quarter.
-
Did Bicara Therapeutics, Inc. Beat Earnings Last Quarter?
Bicara Therapeutics, Inc. announced earnings per share of -$0.67 which represents a miss of analyst forecast a -$0.53 per share.
-
Is Bicara Therapeutics, Inc. Profitable?
Bicara Therapeutics, Inc. reported -$24K that represents -$0.00 per share over the last quarter.
-
What is the Analyst Consensus for Bicara Therapeutics, Inc. EPS Next Year?
Bicara Therapeutics, Inc.'s earnings are forecast to decrease from -$1.25 per share to -$2.64 per share next year representing a decrease of -99.36%.
-
When is Bicara Therapeutics, Inc.'s Earnings Date?
Bicara Therapeutics, Inc.'s next earnings date is March 26, 2026.
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
59
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 65x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
72
GLTO alert for Dec 27
Galecto, Inc. [GLTO] is up 16.92% over the past day.
Sell
20
SMX alert for Dec 27
SMX (Security Matters) Plc [SMX] is down 15.76% over the past day.
Sell
11
CDNAF alert for Dec 27
Canadian Tire Corp. Ltd. [CDNAF] is down 10% over the past day.
